AIDA Network

WebinarOnline

AIDA Seminars 2021 - 3rd Session

Interleukin-1 inhibition in Adult Onset Still's disease, Diagnostic and classification criteria for FMF

Training hours: 1h

Target audience: Specialists in allergy and clinical immunology, gastroenterology, internal medicine, ophthalmology, pediatrics and rheumatology

Event CME credits: 13,5

Programme:

  • 5.00pm Lecture. Interleukin-1 inhibition with Anakinra and Canakinumab in Adult Onset Still's Disease. Expert: Katerina Laskari - Athens (Greece)
  • 5.20pm Lecture. Diagnostic and classification criteria for Familial Mediterranean Fever. Expert: Raffaele Manna - Rome (Italy)
  • 5.40pm Clinical Case. Antonio Vitale - Siena (Italy)
  • 5.50pm Discussion and questions to the expert
  • 6.00pm Closing remarks and CME evaluation